Patent details
EP3846811 Title: COMBINATION OF APREPITANT, BUPIVACAINE, AND MELOXICAM FOR USE IN THE TREATMENT OF POST-SURGICAL PAIN
Basic Information
- Publication number:
- EP3846811
- PCT Application Number:
- US2019050079
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP197831712
- PCT Publication Number:
- WO2020051543
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION OF APREPITANT, BUPIVACAINE, AND MELOXICAM FOR USE IN THE TREATMENT OF POST-SURGICAL PAIN
- French Title of Invention:
- COMBINAISON D'APREPITANT, DE BUPIVACAINE ET DE MELOXICAM POUR L'UTILISATION DANS LE TRAITEMENT DE LA DOULEUR POST-CHIRURGICALE
- German Title of Invention:
- KOMBINATION AUS APREPITANT, BUPIVACAIN UND MELOXICAM ZUR VERWENDUNG BEI DER BEHANDLUNG VON POSTOPERATIVEM SCHMERZ
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 01/12/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 10/12/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 05/11/2025
- Unitary Effect Registration Date:
- 10/12/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 06/09/2019
- Grant date:
- 05/11/2025
- EP Publication Date:
- 14/07/2021
- PCT Publication Date:
- 12/03/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/11/2025
- EP B1 Publication Date:
- 05/11/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 06/09/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 29/10/2025
- Name:
- Heron Therapeutics, Inc.
- Address:
- 4242 Campus Point Court Suite 200, San Diego CA 92121, United States (US)
Inventor
1
- Name:
- QUART, Barry D.
- Address:
- United States (US)
2
- Name:
- OTTOBONI, Thomas B.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201862728732 P
- Priority Date:
- 07/09/2018
- Priority Country:
- United States (US)
2
- Priority Number:
- 201962860190 P
- Priority Date:
- 11/06/2019
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/445; A61K 31/5377; A61K 31/5415; A61P 23/00; A61P 23/02; A61K 9/00; A61K 9/107; A61K 45/06; A61K 47/24;
Publication
European Patent Bulletin
1
- Issue number:
- 202545
- Publication date:
- 05/11/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202602
- Publication date:
- 07/01/2026
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202603
- Publication date:
- 14/01/2026
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|